Harvest Receives CE for its Autologous Point of Care Bone Marrow System Which Concentrates 200 Million Mono-Nucelated Cells Including Stem Cells From a Small 60 CC Sample
PLYMOUTH, Mass., Sept. 21 /PRNewswire/ -- Harvest(R) Technologies Corporation, announced today that it had received authorization to mark its autologous point of care Bone Marrow Concentration Systems with the CE Mark and is seeking distribution within the European Union. The autologous point of care bone marrow concentration kit is a total system that includes all necessary components to rapidly produce a concentrated quantity of mono- nucleated cells, containing stem cells, from a small 60cc sample of bone marrow. The mono-nucleated cells are concentrated seven fold which produces a yield of 200 million cells. The concentrated bone marrow maybe co- administrated with Harvest's autologous thrombin product currently being marketed in Europe. Both products can be produced simultaneously within the SmartPReP System. The Harvest Bone Marrow Concentration System is a completely automated approach that concentrates mono-nucleated cells (200 million) from a small sample (60cc) of the patient's bone marrow within 15 minutes. Since the bone marrow concentration is autologous and is concentrated at point of care a physician is free to use the product within his practice of medicine. The most obvious applications are bone grafting for bone voids and defects eliminating the need for an autologous bone harvest procedures. Concentrated mesenchymal stem cells have demonstrated positive outcomes within the scientific literature for treating Osteonecrosis, Osteoarthritis and for Spinal Disc Regeneration. Harvest is expecting that its new, easy to use System for concentrating these important cells will greatly expand their use and offer the physician an important tool for the treatment of these debilitating conditions. Harvest GMBH located in Munich Germany is currently introducing the Harvest Bone Marrow Concentration Systems to its key customers. Harvest GMBH is planning to have European Distribution in place during the forth quarter of this year. CONTACT: Gary Tureski, President & Co-founder Harvest Technologies Corp. 508-732-7500 email@example.com
SOURCE Harvest Technologies Corporation
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.